Industry News Sponsored by
Naturex's (Avignon, France) 2012 full-year revenue climbed 18.2%, or 13.9% at constant exchange rates, to €299.8 million amid growth in the emerging markets.
Meanwhile, fourth-quarter revenue surged 22.9%, or 20% at constant exchanges rates, to €62.4 million.
By segment, the food and beverage division had 2012 revenue of €188.8 million, up 12.2% (7.7% at constant exchange rates), reflecting a shift in the ingredients range to a larger and more customized offering allowing for a significant number of combinations.
Nutrition and health grew 29.7%, or 22.7% at constant exchange rates for the year, on revenue of €92.3 million sustained by an offering with an increased focus on concepts providing differentiation based on innovative extracts, notably through its NATactiv and NATlife ranges.
Personal care had revenue of nearly €5 million in 2012, a significant gain on the prior year, driven by a more targeted offering for cosmetic applications. Toll manufacturing regained ground in the last two quarters of the period to reach annual sales of €13.9 million, up 28.2% on 2011.
Emerging markets in Eastern Europe, Asia, Latin America, Africa and the Middle East accounted for a 17.7% share of total group revenue, up from 14% a year earlier, with 51.5% year-on-year growth at current exchange rates.
By region, the Europe/Africa region had 2012 revenue growth of 11.1%, or 6.4% at constant exchange rates. The Americas grew 30.4%, or 20.4% at constant exchange rates, driven by very strong continuing expansion in North America and accelerating gains in Latin America. The Asia-Pacific region performed well on the strength of rapid advances in countries in Asia, which now account for 60% of this region after gaining 20% in the period. Naturex Australia expanded its nutraceutical and food and beverage additives offering.